Atlas Trials

The HepatoPancreaticoBiliary Resection Arginine Immunomodulation (PRIMe) Trial

Clinical trial NCT04549662 · COMPLETED

Trial details

NCT number
NCT04549662
Sponsor
Sunnybrook Health Sciences Centre
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hepatopancreaticobiliary (HPB) MalignancySurgery
Start date
2021-06-16
Primary completion
2024-02-12
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.